Department of Orthopaedic Trauma Surgery, Faculty of Medicine, RWTH Aachen University, Pauwelsstraβe 30, 52074 Aachen, Germany.
Mediators Inflamm. 2012;2012:512974. doi: 10.1155/2012/512974. Epub 2011 Oct 20.
Several studies report immunomodulatory effects of endogenous IL-10 after trauma. The present study investigates the effect of inhalative IL-10 administration on systemic and pulmonary inflammation in hemorrhagic shock. Male C57/BL6 mice (8 animals per group) were subjected to pressure-controlled hemorrhagic shock for 1.5 hrs followed by resuscitation and inhalative administration of either 50 μL PBS (Shock group) or 50 μg/kg recombinant mouse IL-10 dissolved in 50 μL PBS (Shock + IL-10 group). Animals were sacrificed after 4.5 hrs of recovery and serum IL-6, IL-10, KC, and MCP-1 concentrations were measured with ELISA kits. Acute pulmonary inflammation was assessed by pulmonary myeloperoxidase (MPO) activity and pulmonary H&E histopathology. Inhalative IL-10 administration decreased pulmonary inflammation without altering the systemic concentrations of IL-6, IL-10, and KC. Serum MCP-1 levels were significantly reduced following inhalative IL-10 administration. These findings suggest that inhalative IL-10 administration may modulate the pulmonary microenvironment without major alterations of the systemic inflammatory response, thus minimizing the potential susceptibility to infection and sepsis.
几项研究报告创伤后内源性 IL-10 具有免疫调节作用。本研究探讨了吸入 IL-10 给药对失血性休克中全身和肺部炎症的影响。雄性 C57/BL6 小鼠(每组 8 只动物)接受压力控制的失血性休克 1.5 小时,然后进行复苏并吸入给予 50 μL PBS(休克组)或 50 μg/kg 重组小鼠 IL-10 溶解在 50 μL PBS 中(休克+IL-10 组)。恢复 4.5 小时后处死动物,并使用 ELISA 试剂盒测量血清 IL-6、IL-10、KC 和 MCP-1 浓度。通过肺髓过氧化物酶 (MPO) 活性和肺苏木精-伊红组织病理学评估急性肺炎症。吸入 IL-10 给药可减轻肺部炎症,而不改变全身 IL-6、IL-10 和 KC 的浓度。吸入 IL-10 给药后血清 MCP-1 水平显著降低。这些发现表明,吸入 IL-10 给药可能调节肺部微环境,而不会对全身炎症反应产生重大改变,从而最大程度地降低感染和败血症的潜在易感性。